← Back to overview

JNJ Johnson & Johnson

Pharmaceuticals · $263.40 +1.59%
EN PL
Price Alert:

Compare

Shows % change over the period so different-priced stocks can be compared fairly.

Technical Indicators

RSI (14)
59.5
Relative Strength Index (RSI): measures how fast and how much the price has moved recently, on a 0-100 scale. Above 70 is often called "overbought" (may be due for a pause or pullback); below 30 is "oversold" (may be due for a bounce). It is not a guarantee either way.
SMA 20 / 50 / 200
255.55 / 241.15 / —
Moving Averages (SMA): the average closing price over the last N days, smoothing out day-to-day noise. When price trades above its moving averages, and shorter averages are above longer ones, it is generally read as a healthier trend.
MACD / Signal
3.53 / 4.42
MACD: compares two moving averages (12-day and 26-day) to gauge momentum. When the MACD line crosses above its signal line, momentum is turning up; crossing below suggests momentum turning down.

Fundamentals

P/E
30.6
Price-to-Earnings ratio: how many dollars investors pay for $1 of the company's annual profit. Higher usually means the market expects faster growth (or the stock is expensive); lower can mean it's cheap — or that growth is expected to slow.
Market Cap
634.77B
Market Capitalization: the total value of all the company's shares — share price × number of shares. A rough measure of company size.
Div Yield
2.03%
Dividend Yield: the annual cash dividend paid to shareholders, as a percentage of the current share price.
52-Week Range
164.23 – 269.43
52-Week Range: the lowest and highest price the stock has traded at over the last year. Where the price sits in this range hints at recent strength or weakness.

Trend Analysis

Johnson & Johnson is trading at $263.40, +1.59% versus the previous close. The price is near its 52-week high — the top of its recent trading range.
RSI is in a neutral range — no strong overbought/oversold signal.
MACD is below its signal line — momentum currently leans negative.
Combine this reading with the fundamentals below before forming a view — no single indicator is a guarantee of what happens next.

Latest News

The $2 Million Retirement Mistake: Confusing Yield With Income You Can Actually Spend
24/7 Wall St. · 2026-07-25 23:48
Claiming Social Security at 62 vs. Building a Dividend Bridge: Which Leaves You Richer at 75?
24/7 Wall St. · 2026-07-25 22:46
Johnson & Johnson Is Becoming A Narrower Company Than You Bought
Trefis · 2026-07-25 14:30
Jim Cramer Says Kimberly-Clark’s Acquisition of Kenvue Creates a High-Margin Powerhouse
Insider Monkey · 2026-07-25 12:22
Jim Cramer Said To Buy Johnson & Johnson (NYSE:JNJ)’s Shares – Here’s What Happened Next
Insider Monkey · 2026-07-25 07:59
Does PayPal Have a Buyer?
Motley Fool · 2026-07-25 01:36
Nasdaq lags on angst over AI spending ahead of earnings reports
Reuters Videos · 2026-07-24 22:19
Johnson & Johnson (JNJ) Reports Early Phase 3 Win In Multiple Myeloma
Simply Wall St. · 2026-07-24 22:12
Educational information only. Nothing here is investment advice — always do your own research and consider talking to a licensed financial advisor before buying or selling.
Data: Yahoo Finance, refreshed periodically and cached locally.